Kaken Pharmaceutical Co Ltd
Company Profile
Business description
Kaken Pharmaceutical Co Ltd is a specialty and generic drug manufacturing company. The company organizes its segments between pharmaceutical and real estate activities. The pharmaceutical segment consists of pharmaceutical drugs, medical devices, and agrochemicals. In the real estate segment, the majority of revenue is generated through commercial facility rental fees. Sales in Japan constitute more than 90% of revenue. Kaken considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
Contact
28-8, Honkomagome 2-chome
Bunkyo-ku
Tokyo1138650
JPNT: +81 359775001
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2026
Employees
1,308
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,723.60 | 17.80 | -0.20% |
CAC 40 | 7,553.45 | 102.67 | -1.34% |
DAX 40 | 23,057.38 | 260.43 | -1.12% |
Dow JONES (US) | 42,171.66 | 44.14 | -0.10% |
FTSE 100 | 8,791.80 | 51.67 | -0.58% |
HKSE | 23,504.59 | 266.85 | 1.15% |
NASDAQ | 19,546.27 | 25.18 | 0.13% |
Nikkei 225 | 38,458.22 | 30.12 | -0.08% |
NZX 50 Index | 12,569.05 | 58.27 | -0.46% |
S&P 500 | 5,980.87 | 1.85 | -0.03% |
S&P/ASX 200 | 8,505.40 | 18.30 | -0.21% |
SSE Composite Index | 3,364.83 | 2.73 | 0.08% |